Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868902 · ClinicalTrials.gov registry record
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
A clinical trial of Coronary; Ischemic, sponsored by Genetesis.
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05868902 is a study of Coronary; Ischemic that is actively recruiting participants, run by Genetesis. The registered enrollment target is 300 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05868902, a study of Coronary; Ischemic, is actively recruiting participants, sponsored by Genetesis.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
Conditions Studied
Interventions
- DEVICE CardioFlux Magnetocardiography
Study Locations (2)
Ohio
- Cleveland Clinic - Cleveland
- Kettering Health - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-08-28 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05868902
The ClinicalTrials.gov registry entry for NCT05868902 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genetesis, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary; Ischemic appearing as the primary indexed condition, and to 1 intervention - of which CardioFlux Magnetocardiography is the first listed.
NCT05868902 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05868902 about?
NCT05868902 is a clinical study titled "A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.". A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
What is the current status of trial NCT05868902?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-08-28. Estimated completion is 2025-12-31.
What conditions does trial NCT05868902 study?
This clinical trial studies the following conditions: Coronary; Ischemic.
What interventions are being tested in trial NCT05868902?
The interventions under investigation include: CardioFlux Magnetocardiography (DEVICE).
Who is sponsoring clinical trial NCT05868902?
This trial is sponsored by Genetesis, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868902 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.